| Schedule of notes payable |
| Schedule of notes payable | |
| | | |
| | | |
| | |
| | |
Interest
Rate | |
December 31,
2025 | |
December 31,
2024 |
| Notes Payable and Convertible Notes Payable | |
| | | |
| | | |
| | |
| | |
| | | |
| | | |
| | |
| In December 2020, the Company entered into a 56- month loan with a company in the amount of $1,578,237. The loan requires payments of 3.75% through November 2022 and 4.00% through September 2025 of the previous month’s revenue. Note was due September 2025. Note is guaranteed by a related party see note 6. | |
| 17 | % | |
$ | 188,839 | | |
$ | 195,927 | |
| | |
| | | |
| | | |
| | |
| In April 2021, the Company entered into two six-month loans in the amount of $84,000 each. The loan had an original maturity of October 2021 with principal and interest due at maturity. The loan was exchanged to Series B Preferred stock in June 2025. | |
| 7 | % | |
| — | | |
| 168,000 | |
| | |
| | | |
| | | |
| | |
| In May 2021, the Company entered into a six-month loan with an individual in the amount of $50,000. The loan had an original maturity of October 2021 with principal and interest due at maturity. The loan was exchanged to Series B Preferred stock in June 2025. | |
| 7 | % | |
| — | | |
| 50,000 | |
| | |
| | | |
| | | |
| | |
| In May 2021, the Company entered into a six-month loan with an individual in the amount of $10,000. The loan had an original maturity of October 2021 with principal and interest due at maturity. The loan due date was extended to October 31, 2024. . | |
| 7 | % | |
| 10,000 | | |
| 10,000 | |
| | |
| | | |
| | | |
| | |
| In August 2022, the Company entered into a 56-months auto loan in the amount of $45,420. | |
| 2.35 | % | |
| 13,514 | | |
| 23,372 | |
| | |
| | | |
| | | |
| | |
| In December 2022, the Company entered into various eighteen-month loans with individuals totaling $4,000,000. The notes included 100% warrant coverage. The loans mature in June 2024 with principal and interest due at maturity with conversion price of $40.00 per share. The loans were exchanged to Series B Preferred stock in June 2025. | |
| 12 | % | |
| — | | |
| 2,600,000 | |
| | |
| | | |
| | | |
| | |
| In December 2022, the Company entered into an eighteen-month loan with an individual in the amount of $1,000,000. The notes included 100% warrant coverage. The loan was exchanged to Series B Preferred stock in June 2025. | |
| 12 | % | |
| — | | |
| 1,000,000 | |
| In May 2023, the Company entered into various eighteen-month loans with individuals totaling in the amount of $800,000. The notes included 50% warrant coverage. The loans mature in November 2024 with principal and interest due at maturity with conversion price of $40.00 per share. The loans were exchanged to Series B Preferred stock in June 2025. | |
| 12 | % | |
| — | | |
| 800,000 | |
| | |
| | | |
| | | |
| | |
| In June 2023, the Company entered into various eighteen-month loans with individuals totaling in the amount of $350,000. The notes included 50% warrant coverage. The loans mature in December 2024 with principal and interest due at maturity with conversion price of $40.00 per share. The loans were exchanged to Series B Preferred stock in June 2025. | |
| 12 | % | |
| — | | |
| 100,000 | |
| | |
| | | |
| | | |
| | |
| In July 2023, the Company entered into a twelve-month loan with an individual in the amount of $100,000. The note included 50% warrant coverage. The loan matures in January 2025 with principal and interest due at maturity with conversion price of $40.00 per share. The loan was exchanged to Series B Preferred stock in June 2025. | |
| 12 | % | |
| — | | |
| 100,000 | |
| | |
| | | |
| | | |
| | |
| In August 2023, the Company entered into a twelve-month loan with an individual in the amount of $300,000. The convertible note included the issuance of 150,000 shares of Common Stocks. The loan matured in August 2024 with principal and interest due at maturity with a conversion price of $34.00 per share and is non-interest bearing. | |
| — | % | |
| 43,000 | | |
| 43,000 | |
| | |
| | | |
| | | |
| | |
| In October 2023, the Company entered into a three-month loan with an individual in the amount of $500,000. The loan matures in January 2024 with principal and interest due at maturity. The loan due date was extended to June 2025. The Required payment was not made. | |
| 10 | % | |
| 500,000 | | |
| 500,000 | |
| | |
| | | |
| | | |
| | |
| In October 2023, the Company entered into a loan with an individual in the amount of $130,000. The loan requires payment of 17% of daily Shopify sales. | |
| — | % | |
| 58,612 | | |
| 66,278 | |
| | |
| | | |
| | | |
| | |
| In October 2023, the Company entered into a eighteen-month loan with individuals totaling in the amount of $1,250,000. The note included 100% warrant coverage. The loan matured in April 2025 with principal and interest due at maturity with conversion price of $40.00 per share. The loan was fully converted to Common Stock in January 2025 | |
| 12 | % | |
| — | | |
| 1,143,449 | |
| In January 2024, the Company entered into a 18-month loan with an individual in the amount of $250,000. The note included 100% warrant coverage. The loan had a maturity of July 2025 with principal and interest due at maturity with conversion price of $20.00 per share. The loan was exchanged to Series B Preferred stock in June 2025. | |
| 12 | % | |
| — | | |
| 250,000 | |
| | |
| | | |
| | | |
| | |
| In February 2024, the Company entered into a 18-month loan with an individual in the amount of $150,000. The note included 100% warrant coverage. The loan had a maturity of August 2025 with principal and interest due at maturity with conversion price of $16.00 per share. The loan was exchanged to Series B Preferred stock in June 2025. | |
| 12 | % | |
| — | | |
| 150,000 | |
| | |
| | | |
| | | |
| | |
| In February 2024, the Company entered into a 6-month loan with an individual in the amount of $315,000. The note included 60% warrant coverage. The loan had a maturity of August 2024 with principal and interest due at maturity with conversion price of $15.20 per share. The loan was exchanged to Series B Preferred stock in June 2025. | |
| 12 | % | |
| — | | |
| 315,000 | |
| | |
| | | |
| | | |
| | |
| In February 2024, the Company entered into a 18-month loan with an entity in the amount of $250,000. The note included 100% warrant coverage. The loan matures in August 2025 with principal and interest due at maturity with conversion price of $18.40 per share. The loan was exchanged to Series B Preferred stock in June 2025. | |
| 12 | % | |
| — | | |
| 250,000 | |
| | |
| | | |
| | | |
| | |
| In April 2024, the Company entered into a commercial financing agreement in the amount of $815,000 and to be paid weekly until the loan is paid in full. | |
| — | % | |
| 331,335 | | |
| 357,127 | |
| | |
| | | |
| | | |
| | |
| In May 2024, the Company entered into an eighteen-month loan with individuals totaling in the amount of $1,850,000. The note included warrant coverage. The loan matures in November 2026 with principal and interest due at maturity with conversion price of $16.00 per share. The loan was exchanged to Series B Preferred stock in June 2025 | |
| — | % | |
| — | | |
| 1,850,000 | |
| | |
| | | |
| | | |
| | |
| In June 2024, the Company entered into a revenue purchase agreement in the amount of $250,000. 4% of revenue will be paid weekly until the loan is paid in full. | |
| — | % | |
| 13,459 | | |
| 181,341 | |
| | |
| | | |
| | | |
| | |
| In July 2024, the Company entered into a revenue purchase agreement in the amount of $178,250. The loan matures in April 2025. The loan was fully converted to Common Stock in January 2025. | |
| 22 | % | |
| — | | |
| 91,999 | |
| In July 2024, the Company entered into a revenue purchase agreement in the amount of $120,750. The loan matures in May 30, 2025. The loan was fully converted to Common Stock in January 2025 | |
| 22 | % | |
| — | | |
| 120,750 | |
| | |
| | | |
| | | |
| | |
| In August 2024, the Company entered into a 5-year loan with individuals totaling in the amount of $500,000. The loan matures in September 2029 with principal and interest due at maturity with conversion price of $14.00 per share. The loans were exchanged to Series B Preferred stock in June 2025. | |
| 9 | % | |
| — | | |
| 500,000 | |
| | |
| | | |
| | | |
| | |
| In August 2024, the Company entered into a eighteen-month loan with individuals totaling in the amount of $1,400,000. The loan matures in February 2026 with principal and interest due at maturity with conversion price of $0.38 per share. $800,000 was exchanged to Preferred stock in June 2025. | |
| 12 | % | |
| — | | |
| 1,400,000 | |
| | |
| | | |
| | | |
| | |
| In August 2024, the Company entered into a eighteen-month loan with individuals totaling in the amount of $100,000. The loan matures in September 2025 with principal and interest due at maturity with conversion price of $15.20 per share. The loan was exchanged to Series B Preferred stock in June 2025. | |
| 12 | % | |
| — | | |
| 100,000 | |
| | |
| | | |
| | | |
| | |
| In September 2024, the Company entered into a merchant cash advance agreement in the amount of $325,000 to be paid weekly until the loan is paid in full. | |
| — | % | |
| 10,861 | | |
| 82,261 | |
| | |
| | | |
| | | |
| | |
| In September 2024, the Company entered into an agreement with individuals totaling in the amount of $590,000. There is no stated maturity, the proceeds of which are to be used for a future acquisition. $290,000 was exchanged to Series B Preferred stock in June 2025 | |
| — | % | |
| 300,000 | | |
| 590,000 | |
| | |
| | | |
| | | |
| | |
| In October 2024, the Company entered into an agreement with individuals totaling in the amount of $950,000. There is no stated maturity, the proceeds of which were to be used for a future acquisition which did not occur. | |
| — | % | |
| 950,000 | | |
| 950,000 | |
| | |
| | | |
| | | |
| | |
| In November 2024, the Company entered into a merchant cash advance agreement in the amount of $340,000 to be paid weekly until the loan is paid in full. | |
| — | % | |
| 256,713 | | |
| 311,713 | |
| | |
| | | |
| | | |
| | |
| In December 2024, the Company entered into a merchant cash advance agreement in the amount of $111,300 to be paid weekly until the loan is paid in full. The loan was fully converted to Common Stock. | |
| — | % | |
| — | | |
| 111,300 | |
| In December 2024, the Company entered into a twelve-month loan with an individual in the amount of $225,000 . The loan matured in December 2025 with principal and interest due at maturity. | |
| 12 | % | |
| 225,000 | | |
| 225,000 | |
| | |
| | | |
| | | |
| | |
| In January 2025, the Company entered into a 12-month loan with individuals in the amount of $350,000. The note included 100% warrant coverage. The loan had a maturity of January 2026 with principal and interest due at maturity with conversion price of $10.00 per share. The loans of $150,000 were exchanged to Series B Preferred stock in June 2025. | |
| 12 | % | |
| 200,000 | | |
| — | |
| | |
| | | |
| | | |
| | |
| In July 2025, the Company entered into a convertible promissory note in the amount of $30,000. The loans was due on August 31, 2025 | |
| 12 | % | |
| 30,000 | | |
| — | |
| | |
| | | |
| | | |
| | |
| In August 2025, the Company entered into a convertible promissory note with individuals totaling in the amount of $241,280. The loan had a maturity of May 2026 with principal and interest due at maturity. The loans are convertible at 75% multiplied by the lowest trading price for the Company’s common stock during the 10 trading day period ending on the latest complete trading day prior to the conversion date, subject to a 4.99% equity blocker. | |
| 22 | % | |
| 241,280 | | |
| — | |
| In August 2025, the Company entered into a convertible promissory note in the amount of $183,280. The loan had a maturity of June 2026 with principal and interest due at maturity. The loans are convertible at 75% multiplied by the lowest trading price for the Company’s common stock during the 10 trading day period ending on the latest complete trading day prior to the conversion date, subject to a 4.99% equity blocker | |
| 22 | % | |
| 183,280 | | |
| — | |
| | |
| | | |
| | | |
| | |
| In September 2025, the Company entered into a twelve-month loan with individuals totaling in the amount of $2,200,000. The loan matures in September 2026 with principal and interest due at maturity and is convertible into the Company’s Common Stock at a conversion price equal to the lower of $1.75 and $0.01 above the closing price on the date of conversion. | |
| 0 | % | |
| 2,200,000 | | |
| — | |
| | |
| | | |
| | | |
| | |
| In November 2025, the Company entered into a twelve-month loan with individuals totaling in the amount of $500,000. The loan matures in November 2026 with principal and interest due at maturity and is convertible into the Company’s Common Stock at a conversion price equal to the lower of $1.75 and $0.01 above the closing price on the date of conversion. | |
| 0 | % | |
| 500,000 | | |
| — | |
| | |
| | | |
| | | |
| | |
| | |
| Total notes payable | | |
$ | 6,255,893 | | |
$ | 14,635,517 | |
| | |
| | | |
| | | |
| | |
| | |
| Less notes discount | | |
| (26,894 | ) | |
| (3,031,917 | ) |
| | |
| Less current portion | | |
| (6,225,581 | ) | |
| (9,632,505 | ) |
| | |
| | | |
| | | |
| | |
| | |
| Long-term notes payable | | |
$ | 3,418 | | |
$ | 1,971,095 | |
|